Short Interest in BioRestorative Therapies, Inc. (NASDAQ:BRTX) Rises By 129.3%

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totalling 153,400 shares, an increase of 129.3% from the November 30th total of 66,900 shares. Approximately 3.0% of the company’s stock are short sold. Based on an average daily volume of 47,600 shares, the short-interest ratio is currently 3.2 days.

BioRestorative Therapies Stock Up 0.6 %

Shares of NASDAQ:BRTX opened at $1.55 on Friday. The firm has a 50 day moving average of $1.52 and a 200 day moving average of $1.63. The company has a market capitalization of $10.73 million, a price-to-earnings ratio of -1.01 and a beta of 62.59. BioRestorative Therapies has a 52 week low of $1.03 and a 52 week high of $3.67.

BioRestorative Therapies (NASDAQ:BRTX) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.22. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The firm had revenue of $0.23 million during the quarter, compared to analyst estimates of $0.30 million. On average, sell-side analysts expect that BioRestorative Therapies will post -1.43 EPS for the current year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.